Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics.

J Clin Med · 2020 · PMC7599534 · PMID 32992732

Europe PMC DOI

hedged sentence

0.0859

closest p · 1.7× alpha

0.0859

boldest claim

The sentences

a clear trendp = 0.0859so close (0.05 < p ≤ 0.1)

There was a clear trend ( p = 0.0859) towards lower BCL-2 expression in patients with monocytic AML, defined here on the basis of CD64 positivity [ 26 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.